We are interested in studying tumour cell heterogeneity in human lung cancer. The development of methods for cloning human tumour cells in agar (Courtenay & Mills, 1978; Hamburger & Salmon, 1977) has provided a means of selecting individual cell colonies and thereby establishing clonal subpopulations. However, using agarose instead of agar in their systems, Carney et al. (1980) and others have shown that the plating efficiencies (PE) of human lung cancer specimens direct from the patient and early cell cultures derived from such specimens are usually < 1%. Such low PE may reflect a selectivity on clonal growth resulting in an unnecessarily narrow range of colony types. The aim of this study was to determine optimal cloning conditions which would promote the growth of as wide a range of colony types as possible. The methods of Courtenay & Mills (1978) and Carney et al. (1980) were used to examine the effect of various factors upon the clonogenicity of human lung cancer cells.
Materials and methods
The clonogenic assay methods used in these studies were those of Courtenay & Mills (1978) (the 'Courtenay method') and of Carney et al. (1980) (the 'Carney method').
The Courtenay method
The medium used in this method was modified Hams F12 supplemented with 15% foetal calf serum and with penicillin and streptomycin (all supplied by Gibco Biocult Ltd UK). Red blood cells (RBC) were obtained by cardiac puncture on August rats using preservative-free heparin, rinsed 3 Correspondence: G.A. Walls. Received 14 December 1984; and in revised form 1 July 1985. times with PBS and resuspended to the original blood volume in medium. The RBC suspension was then heated to 44°C for 1 h and stored at 4°C for up to one month. An 1/8 dilution in medium of the RBC was carried out immediately before use. A 6% solution of Agar Noble (Difco) was prepared in either distilled water or PBS and sterilized by boiling for 15 min. This was then diluted 1/10 in medium prewarmed at 44°C to give a final concentration of 0.6% and the solution kept at 44°C until required. Suspensions of the test cells in medium were prepared (as below) at 2.5 x the required final concentration and *kept at 37°C.
Immediately prior to plating, 2.0ml of the test cell suspension was added to 0.5ml of RBC suspension followed by 2.5ml of 0.6% agar solution. Aliquots of 1ml of this suspension were then placed into each of 3 or 4 sterile plastic tubes with round bottoms (Falcon 2051). These tubes were allowed to stand in crushed ice until the agar set. They were then each gassed for 6s with a mixture of 90% N2, 5% 02 and 5% CO2 and the top of each tube 'snapped' closed. The tubes were placed in racks in plastic boxes which were then gassed with the same mixture for 10min before being sealed and incubated at 37°C in a walk-in warm room. After 7 and 14 days of incubation, 1 ml of medium was added to the agar plug in each tube and the tubes and boxes regassed. In those tubes where incubation continued for 4 or more weeks (i.e. in experiments with material other than established cell lines), 1 ml of medium was replaced with fresh medium at 21 days and weekly thereafter. At the end of the incubation period, the agar plug was tipped out from each tube into the inverted lid of a 5cm plastic petri dish. The base of the dish was then pushed down onto the plug so that the agar spread in a thin layer. Colonies containing >50 cells were counted under an inverted microscope. In some experiments, heavily-irradiated (100 Gy of 250kv X-rays) cells (HR) were included in the live cell suspensions. These HR cells were always of thesame type as the live cells being tested. The gas mixture was also varied in some experiments in which tubes were gassed with either 95% air plus 5% CO2 or 95% N2 plus 5% CO2 as alternatives to the usual mixture. The effect of omitting RBC was also studied.
The Carney method The medium used in this method was RPMI 1640 supplemented with 20% heat-inactivated foetal calf serum and with penicillin and streptomycin (all supplied by Gibco Biocult Ltd. UK). A 5% solution of LGT Agarose ('Sea Plaque', Marine Colloids Inc. USA) in distilled water was prepared and sterilized by boiling for 15min. This was then diluted 1/10 in prewarmed medium (44°C) to give a final concentration of 0.5%, and 2ml aliquots of this agarose were pipetted into 35mm plastic petridishes (Falcon) and placed in the refrigerator to harden. A 6% solution of agarose in distilled water was also prepared, diluted 1/10 with medium to give a final concentration of 0.6% and kept at 44°C. Suspensions of the test cells in medium were prepared (as below) at 2 x the required final concentration and kept at 37°C. Immediately before plating, 2.5 ml of the test suspension was mixed with 2.5 ml of 0.6% agarose solution and aliquots of 1 ml were then pipetted into each of 3 or 4 of the 35mm petri dishes containing the agarose 'bottom layer' and recently removed from the refrigerator. The plates were placed into plastic boxes which were then gassed for 10 min with a mixture of 95% air and 5% C02 and incubated at 37°C in a walkin warm room, Plates were examined and colonies containing >50 cells were counted under the inverted microscope at 7-9, 12-16 or 21-22 days after plating. The agarose used in these studies is slightly different from the HGT agarose ('Sea Kem', Marine Colloids Inc.) used by Carney et al. (1980) Xenografts of NCI-H69, COR-L23, COR-L24, COR-L31, COR-L32, COR-L47 and COR-L51 were grown intramuscularly in the gastrocnemius muscle of the hind limbs of MF1 nu/nu mice. They were excised when 0.5 to 1.0g in weight. Tumours were disaggregated to a single cell suspension by mincing with scissors, agitating in medium containing neutral protease at 1 mg ml-1 for 2 h and filtering through cotton gauze. The yield of viable nucleated cells as determined by phasecontrast microscopy was 3-6 x 106 per tumour.
Results

Comparison of clonogenic assays
Data for experiments comparing the two clonogenic methods are shown in Table I .6 x 10-1 3.9 x 10-1 1.9 x 10-1 8.5 x 10-3 POC 7.1 x 10-1 6.1 x 10-1 3.0 x 10-1 3.8 x 10-2 Large cell COR-L23 l.9x10-1 2.1x10-1 9.2x10-2 3.3x10-2 Adenocarcinoma MOR 6.8 x 10-2 1.1 x 10-1 5.2 x 10-2 1.7 x 10-3
Recent in vitro SCLC specimensb COR-L32 2.7 x 10-1 9.1 x 10-2 2.6 x 10-4 2.4 x 10-4 COR-L24 In the description of their method, Courtenay & Mills (1978) used distilled water as a solvent for agar but more recently Courtenay (1983) describes using PBS for this purpose. Therefore, we compared PBS with distilled water as a solvent for the agar in the cloning of COR-L24 and COR-L32. For both cell cultures, PBS appears to give a PE 2-3 times higher than that produced when using distilled water (results not shown).
Also, Courtenay (1983) suggests an incubation period of 4 weeks. However, this length of time was sub-optimal for specimens from the patient which we found to form only small colonies of usually <50 cells after 4 weeks in culture. Table III 1.0x 10-5 2.0x 10-5 3.0x 10-6 ND Xenografts 3.l x 10-l 4.3 x 10-6.7 x 10-I ND ND COR-L24 2.9 x 10-3 5.0 x 10-3 4.8 x 10-3 8.6 x 10-3 ND 7.5x 10-3 2.4x 10-2 1.7x 10-2.4x 10-ND ND, not done. In the Carney method, colonies rarely appeared before day 7 of incubation and because no replenishment of the medium is carried out in this method, experiments were generally scored before day 21. During this period of incubation the PE of most cell specimens increased (Table VI) . Cultures of all specimens contained small clusters of <50 cells which were not scored. In the case of NCI-H69, these small clusters were scored separately from the usual colonies. The ratio of colonies:clusters was, on day 9 of incubation, 0:33; on day 12, 7:94; and on day 15, 17:72. It seems likely that by day 12, all cells destined to produce small clusters would have done so; some of these growing to consist of more than 50 cells during the interval from day 12 to day 15 and therefore scored as colonies not clusters. aColonies counted after 14 days in culture. (Bradley & Metcalf, 1966; Metcalf et al., 1967; Bradley et al., 1971) . Using the Carney method, Carney et al. (1980) reported no colonies being formed from 7 bone marrow specimens histologically negative for SCLC. Although the PE of our normal bone marrow specimens in the Carney method was low, they still gave large colonies consisting of >50 cells that ranged in number from 2 (NMB 4) to 20 (NBM 3) for 105 cells plated. The colonies formed from normal bone marrow were of 2 distinct types (1) diffuse groups of cells (not scored) and (2) tightly packed clusters of cells similar to colonies produced by SCLC specimens. Colonies of the latter type will make it difficult to select colonies from bone marrow specimens with SCLC infiltration if the specimen is cloned direct from the clinic.
There are several reasons which may explain why the Courtenay method produces higher PE than the Carney method. The two most critical factors appear to be the presence of rat RBC and low 02 concentration. Bradley et al. (1971) first demonstrated that washed rat RBC improved the clonogenicity of mouse marrow cells and produced larger colonies. RBC lysed before use were found to be equally effective as whole cells in promoting colony growth suggesting the release of a growth factor. However, using human tumour xenografts, Courtenay & Mills (1978) found that RBC lysed before use were less effective than whole cells and that the time of lysis in culture is important. RBC from August rats were superior to RBC from other strains of rat because they lysed over a period of 5-7 days, a critical time for colony growth. Also, the PE of various cell types seems dependent on an optimal number of RBC (Bradley et al., 1971; Courtenay & Mills, 1978; Courtenay, 1983) . We found that there is a general requirement for rat RBC although the 2 non-small cell lines (COR-L23 & MOR) appear less dependent upon them than the NCI-H69 cell line. Indeed, NCI-H69 cells seem very sensitive to the concentration of RBC since the PE was found to be gradually reduced as the RBC were diluted from 1/8 to 1/64. In the absence of RBC, the PE of these cells was < 50% of the PE at the lowest dilution.
Recently, Tveit et al. (1981a; 1981b) (Richter et al., 1972; Courtenay, 1976 Courtenay, , 1985 Gupta & Krishan, 1982 (1984) have observed large variations in clonogenic cell growth between replicate cell plates placed in several different gassing incubators. These authors suggest that the different PE may be related to differences in water loss from the agar which was found to occur during incubation.
Prolonged incubation periods in the Courtenay method were necessary for specimens cloned direct from the patient and for 1 of 3 xenografts of early culture specimens (COR-L32). For all specimens except COR-L92 and COR-L93 which were diagnosed negative for tumour cells, there was a considerable increase in PE between 4 and 6 weeks. In one case (COR-L90) the clonogenicity was still increasing at 12 weeks. The Courtenay method has a particularly useful advantage over the Carney method as it is possible to replensih the medium and thus maintain slow-growing colonies over long periods of time. In fact the weekly replenishment of the medium over the usual 3 to 4 week period may be responsible for the generally higher PE seen routinely with the Courtenay method. It is apparent that, for the cells studied, an incubation period in excess of 9 days is required for colony formation in the Carney method. Even NCI-H69 plated at 5 times the number of cells used in the Courtenay method failed to produce colonies during the first week. Although 4 specimens showed a continual increase in PE up to 3 weeks, the cultures could not be maintained longer than 3 weeks because in the Carney method, the agarose is not replenished.
In conclusion we have shown that the Courtenay method provides higher PE than the Carney method for human SCLC cells including specimens direct from the patient, early cell cultures and established cell lines. The improved clonogenicity in the Courtenay method is due primarly to the presence of RBC and low 02 tension although the replenishable nature of the assay allows for extremely long incubation periods often necessary for specimens cloned directly from the patient.
